FDA Adverse Event Injury Summary report: N

CLARIVEIN

MDR report key: 5386159 · Received January 22, 2016

Report

Report Number
3005831739-2015-00006
Event Type
Injury
Date Received
January 22, 2016
Date of Event
November 17, 2015
Report Date
December 17, 2015
Manufacturer
VASCULAR INSIGHTS LLC
Product Code
KRA
PMA / PMN Number
071468
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE PERFORMED AS DESIGNED WITH NO MALFUNCTION. DEVICE NOT MADE AVAILABLE BY PHYSICIAN.

Description of Event or Problem · 1

PATIENT HAD REFLUX IN THE LEFT AND RIGHT GSV CONFIRMED BY ULTRASOUND. ON (B)(6) 2015 THE PHYSICIAN USED THE CLARIVEIN IC INFUSION CATHETER TO INFUSE PHYSICIAN SPECIFIED MEDICATION TO THE PERIPHERAL VASCULAR. THE LEFT GSV, PROXIMAL AND DISTAL, WAS TREATED WITH A SCLEROSING AGENT IN 2 SEGMENTS DUE TO THE LENGTH OF THE VEIN. ON (B)(6) 2015 THE RIGHT GSV, PROXIMAL AND DISTAL, WAS TREATED IN 2 SEGMENTS DUE TO THE LENGTH OF THE VEIN. THREE DAYS POST PROCEDURE ULTRASOUND CONFIRMED NO COMPLICATIONS AND BOTH GSV'S CLOSED. ON (B)(6) 2015 DVT WAS IDENTIFIED IN THE LEFT POPLITEAL VEIN, THE LEFT FEMORAL VEIN MID DISTAL AND LEFT GASTROCNEMIUS VEIN; THE TREATED VEINS REMAINED CLOSED PER ULTRASOUND. ON (B)(6) 2015 COMPLICATED BY DEVELOPMENT OF LEFT LOWER EXTREMITY DVT AND BILATERAL PULMONARY EMBOLI, AN IVC FILTER WAS PLACED AND CATHETER DIRECTED VENOUS THROMBOLYSIS WITH TPA WAS PRESCRIBED. ON (B)(6) 2015 ASPIRATION THROMBECTOMY OF THE SUPERFICIAL FEMORAL AND PROXIMAL POPLITEAL VEINS WAS PERFORMED; THE THROMBOLYSIS PROCEDURE WAS TERMINATED AND FILTER REMOVED; INTRAVENOUS HEPARIN ANTICOAGULATION THERAPY WAS RESUMED. THE PATIENT IS LAST REPORTED ON (B)(6) 2015 AS IMPROVING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
43936 CLARIVEIN CONTINUOUS FLUSH CATHETER KRA VASCULAR INSIGHTS LLC N/A N/A

Patients

Seq Age Sex Outcome Treatment
1 31 YR Hospitalization